Program
 
Date: 3rd-4th May, 2016
Venue: NTUH International Convention Center (台大醫院國際會議中心)
  No.2, Xuzhou Rd., Zhongzheng Dist., Taipei City 100, Taiwan (100台北市中正區徐州路2號)
   
Date: May 3, 2016 (Tuesday)
Venue: Room 301, NTUH International Convention Center
Time Topics Speakers
8:30~9:00 Registration
Day-to-Day Operations for Drug Development
9:00~9:10 Opening Remarks
莊裕澤 主任
國研院科技政策研究與資訊中心
Dr. Yuh-Jzer Joung

Director General, Science & Technology Policy Research and Information Center
(STPI),                                     National Applied Research
Laboratories (NARLabs)


張鴻仁副理事長
台灣研發型生技新藥發展協會  
Hong-Jen Chang, M.D., M.P.H.
Vice Chairman, TRPMA
9:10~10:10 Session 1 : Project Manager’s view of Drug Development – Building a generic/universal drug development plan (a check list) for new drug development (small/biologics)
1. Project/Program Team assembly / management
2. Project Plan building based on development               milestones
 a. Lead Declaration (for current chemical series)    
   b. Commit to Lead Optimization to Candidate                Selection
   c. Candidate Selection to IND Submission /First              time in human (FTIH) Approval
 d. Commit to FTIH to Proof of Concept (POC) / End        of Phase 2 (EOP2) Meeting /Commit to Product          Development
 e. PoC to Commit to Phase III
 f. Commit to Phase III to Global Market Application
  Preparation/Submission (regulatory)
   g. Submit BLA/NDA/MAA/J-NDA to Market Launch
Lei Chuang
10:10-10:25 Q&A
10:25-10:45 Coffee break
10:45-11:45 Session 2 : Product Development Process
1. Product Development Process Trend – ICH Q8 and     Q11
2. CMC Product and Process Developmental hurdles       –building a product and process development             roadmap to turn potential road block into                   opportunity
3. CMC Regulatory Compliance - manufacturing             facility and analytical testing laboratory to ensure       cGMP compliance in day-to-day operation
Frank Lee
11:45-12:00 Q&A
Afternoon Round-table Session – Hand-on exercises with case-studies
Time Topics
14:00-15:20
Part A

15:20-15:40
Switch Room

15:40-17:00
Part B
Track 1 Track 2
Venue: Room 202, NTUH International Convention Center Venue: Room 402A, NTUH International Convention Center
Speaker: Lei Chuang Speaker: Frank Lee
1. Assembly your Project Development
 Team
2. How to use your competitor’s
 Package Insert/your TPP to build a
 development plan
3. Now you have a plan – how to use it?
1. How to design and manage a
 Product Development Plan?
2. If you have an in-house
 manufacturing facility and analytical
 testing labs, how to operate under
 cGMP compliance?
3. If you use a CMO for manufacturing
 and/or CRO for analytical testing,
 how to select and assure they are
 under cGMP compliance?
 
Date: May 4, 2016 (Wednesday)
Venue: Room 301, NTUH International Convention Center
Time Topics Speakers
8:30~9:00 Registration
Preparation of FDA Submissions and Regulatory Compliance (INDs, NDAs, BLAs, ANDAs, biosimilar, post-approval supplements)
09:00-10:00 Session 3: FDA submission process and practice (i.e., INDs, NDAs, BLAs, ANDAs)
1. An overview of global regulatory process for new drug
 development
2. Communication with Agency - FDA meetings
3. ICH 21 CFR 312- IND submission
4. eCTD preparation
5. BLA/NDA Submission/Review/Approval process (PDUFA V)
6. ANDA submission
Lei Chuang
10:00-10:15 Q&A
10:15-10:35 Coffee break
10:35-11:35 Session 4 : CMC regulatory preparation
1. CMC dossier preparation for IND/BLA/NDA
2. CMC dossier preparation for EMA
3. CMC dossier preparation for other areas (e.g., JNDA)
Frank Lee
11:35-11:50 Q&A
 
Afternoon Round-table Session – Hand-on Exercises with case-studies
Time Topics
14:00-15:20
Part A

15:20-15:40
Switch Room

15:40-17:00
Part B
Track 1 Track 2
Venue: Room 202, NTUH International Convention Center Venue: Room 203, NTUH International Convention Center
Speaker: Lei Chuang Speaker: Frank Lee
1. Prepare a submission plan
2. Calculate your review time
1. Regulatory writing for CMC vs.
 Technical Writing
2. Hand-on eCTD Module Writings with
 examples – DS, DP, and/or Analytical